Sirona Biochem Corp (SBM):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Sirona Biochem Corp (SBM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8081
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sirona Biochem Corp (Sirona Biochem) is a biotechnology company that discovers and develops therapeutics, cosmeceuticals and biological ingredients. The company develops drugs for diabetes and cancer. It provides cosmeceutical programs such as development of anti-aging and depigmenting agents, biological ingredients and inducers and adjuvant for biological development. Sirona Biochem offers products such as sodium glucose transporter inhibitors, cancer antigen, skin brightener, depigmenting agent, anti-aging cosmetic ingredients, inducers and adjuvant, among others. The company offers TFchem for annalogs of existing glycoconjugates, neo-glycosylation of active molecular, new chemical entities, and others. The company operates in Canada, France, and others. Sirona Biochem is headquartered in Vancouver, British Columbia, Canada.

Sirona Biochem Corp (SBM) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Sirona Biochem Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Sirona Biochem Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Sirona Biochem Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Sirona Biochem Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Sirona Biochem Corp, Medical Devices Deals, 2012 to YTD 2018 10
Sirona Biochem Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Sirona Biochem Corp, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
Sirona Biochem Enters Into Licensing Agreement With Cincinnati Children’s Hospital Medical Center 13
Sirona Biochem Enters into Research Agreement with University of British Columbia 14
Sirona Biochem Enters Into Joint Venture Agreement With Bloom Burton 15
Sirona Biochem Enters Into Agreement With Cincinnati Children’s Hospital To Create Novel Skin Care Technology 16
Licensing Agreements 17
Sirona Biochem Expands Licensing Agreement with Valeant Pharma 17
Sirona Biochem Enters Into Licensing Agreement With Obagi Medical For TFC-849 18
Sirona Biochem Enters into Licensing Agreement with Wanbang Biopharma for SGLT2 Inhibitor 19
Equity Offering 21
Sirona Biochem Raises USD0.53 Million in Equity Offering of Units 21
Sirona Biochem Raises USD0.4 Million in Private Placement of Shares 22
Sirona Biochem Raises USD0.6 Million in Private Placement of Units 23
Sirona Biochem Raises USD0.8 Million in Private Placement of Shares up on Exercise of Warrants 24
Sirona Biochem Raises USD0.94 Million in Private Placement of Shares upon Exercise of Warrants 25
Sirona Biochem Completes Private Placement Of Shares For US$1 Million 26
Sirona Biochem Announces Private Placement Of Units For US$5 Million 27
Sirona Biochem Completes Private Placement Of Units For US$1 Million 28
Sirona Biochem Completes Second Tranche Of Private Placement Of Units For US$0.38 Million 29
Sirona Biochem Completes Private Placement Of Units For US$1.41 Million 30
Debt Offering 31
Sirona Biochem Raises USD0.43 Million in Private Placement of Convertible Notes 31
Sirona Biochem Raises USD0.5 Million in Private Placement of Convertible Notes Due 2018 32
Sirona Biochem Corp – Key Competitors 33
Sirona Biochem Corp – Key Employees 34
Sirona Biochem Corp – Locations And Subsidiaries 35
Head Office 35
Other Locations & Subsidiaries 35
Recent Developments 36
Corporate Communications 36
Oct 30, 2017: Sirona Announces Resignation of Board Director 36
Sep 13, 2017: Sirona Biochem Announces Resignation of Board Director 37
Feb 16, 2017: Sirona Biochem Announces Management Changes 38
Product News 39
Jan 31, 2018: Sirona Biochem Announces Development of Anti-Wrinkle Treatment and Update from J.P. Morgan Healthcare Conference 39
Product Approvals 40
Jan 29, 2018: Sirona Biochem Announces Receipt of $500,000 US Milestone Payment 40
Dec 29, 2017: Sirona Biochem Announces SGLT2 IND Submission Milestone 41
Clinical Trials 42
Aug 28, 2018: Sirona Biochem receives $500,000 USD milestone payment from Wanbang Biopharmaceuticals 42
Jul 12, 2018: Sirona Biochem Announces CFDA Approval of SGLT2 Inhibitor for Phase I Clinical Trial 43
Other Significant Developments 44
Dec 19, 2017: Sirona Biochem Announces Results of AGM & CEO Update 44
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
Sirona Biochem Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Sirona Biochem Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Sirona Biochem Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Sirona Biochem Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Sirona Biochem Corp, Deals By Therapy Area, 2012 to YTD 2018 9
Sirona Biochem Corp, Medical Devices Deals, 2012 to YTD 2018 10
Sirona Biochem Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Sirona Biochem Enters Into Licensing Agreement With Cincinnati Children's Hospital Medical Center 13
Sirona Biochem Enters into Research Agreement with University of British Columbia 14
Sirona Biochem Enters Into Joint Venture Agreement With Bloom Burton 15
Sirona Biochem Enters Into Agreement With Cincinnati Children's Hospital To Create Novel Skin Care Technology 16
Sirona Biochem Expands Licensing Agreement with Valeant Pharma 17
Sirona Biochem Enters Into Licensing Agreement With Obagi Medical For TFC-849 18
Sirona Biochem Enters into Licensing Agreement with Wanbang Biopharma for SGLT2 Inhibitor 19
Sirona Biochem Raises USD0.53 Million in Equity Offering of Units 21
Sirona Biochem Raises USD0.4 Million in Private Placement of Shares 22
Sirona Biochem Raises USD0.6 Million in Private Placement of Units 23
Sirona Biochem Raises USD0.8 Million in Private Placement of Shares up on Exercise of Warrants 24
Sirona Biochem Raises USD0.94 Million in Private Placement of Shares upon Exercise of Warrants 25
Sirona Biochem Completes Private Placement Of Shares For US$1 Million 26
Sirona Biochem Announces Private Placement Of Units For US$5 Million 27
Sirona Biochem Completes Private Placement Of Units For US$1 Million 28
Sirona Biochem Completes Second Tranche Of Private Placement Of Units For US$0.38 Million 29
Sirona Biochem Completes Private Placement Of Units For US$1.41 Million 30
Sirona Biochem Raises USD0.43 Million in Private Placement of Convertible Notes 31
Sirona Biochem Raises USD0.5 Million in Private Placement of Convertible Notes Due 2018 32
Sirona Biochem Corp, Key Competitors 33
Sirona Biochem Corp, Key Employees 34
Sirona Biochem Corp, Subsidiaries 35

List of Figures
Sirona Biochem Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sirona Biochem Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sirona Biochem Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sirona Biochem Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sirona Biochem Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Sirona Biochem Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Sirona Biochem Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Sirona Biochem Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Sirona Biochem Corp, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Sirona Biochem Corp (SBM):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Asda Stores Ltd:戦略・SWOT・企業財務分析
    Asda Stores Ltd - Strategy, SWOT and Corporate Finance Report Summary Asda Stores Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Twenty-First Century Fox Inc. (FOXA):企業の財務・戦略的SWOT分析
    Twenty-First Century Fox Inc. (FOXA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Team Health Holdings Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Team Health Holdings Inc (TeamHealth) is a healthcare organization that offers patient care and healthcare services. The organization’s services include hospital medicine, emergency medicine, anesthesiology, hospital medicine subspecialties, ambulatory care, post-acute care, and behavioral h …
  • Sunshine Oilsands Ltd (2012):石油・ガス:M&Aディール及び事業提携情報
    Summary Sunshine Oilsands Ltd (Sunshine Oilsands) is an oil and gas company that develops holdings of oil sands and PN&G leases. The company owns and controls oil sands leases. Its properties include Thickwood, West Ells, Muskwa, Harper, Legend Lake and Portage, among others. Sunshine Oilsands also …
  • Coca-Cola Consolidated Inc (COKE):企業の財務・戦略的SWOT分析
    Coca-Cola Consolidated Inc (COKE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Occidental Petroleum Corp (OXY):石油・ガス:M&Aディール及び事業提携情報
    Summary Occidental Petroleum Corp (Occidental) is an oil and gas exploration and production company with integrated assets. The company is active in upstream exploration and production; midstream and marketing; and chemicals business. The oil and gas business explores for, develops and produces oil, …
  • Kyushu Electric Power Company, Incorporated:企業の戦略・SWOT・財務分析
    Kyushu Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Kyushu Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Ube Industries Ltd (4208):企業の財務・戦略的SWOT分析
    Ube Industries Ltd (4208) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • MISC Bhd (MISC):企業の財務・戦略的SWOT分析
    MISC Bhd (MISC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Wood Group Mustang Inc:企業の戦略的SWOT分析
    Wood Group Mustang Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Argonaut Gold Inc.:企業の戦略・SWOT・財務情報
    Argonaut Gold Inc. - Strategy, SWOT and Corporate Finance Report Summary Argonaut Gold Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Myriad Genetics, Inc.:企業の戦略・SWOT・財務情報
    Myriad Genetics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Myriad Genetics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Mecklenburg Electric Cooperative:企業の戦略的SWOT分析
    Mecklenburg Electric Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • KEC International Ltd:企業の戦略・SWOT・財務情報
    KEC International Ltd - Strategy, SWOT and Corporate Finance Report Summary KEC International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Ulster Bank Ireland DAC:企業の戦略的SWOT分析
    Ulster Bank Ireland DAC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Perenco Holdings:石油・ガス:M&Aディール及び事業提携情報
    Summary Perenco Holdings (Perenco) is an independent upstream energy company. It explores for, develops, produces, transports, and stores oil and gas. The company’s oil fields ranges from Northern Europe to Africa and Latin America to Southeast Asia. Through spot sales and long term sales agreements …
  • Berkeley Energia Ltd:企業の戦略・SWOT・財務分析
    Berkeley Energia Ltd - Strategy, SWOT and Corporate Finance Report Summary Berkeley Energia Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Mount Tam Biotechnologies Inc (MNTM)-製薬・医療分野:企業M&A・提携分析
    Summary Mount Tam Biotechnologies Inc (Mount Tam Biotechnologies), a subsidiary of TabacaleraYsidron Inc is a provider of pharmaceutical products that focuses on the development and commercialization of medical compounds for autoimmune diseases. The company’s lead product candidate TAM-0, a rapamyci …
  • Schneider Electric SE (SU):企業の財務・戦略的SWOT分析
    Schneider Electric SE (SU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Arena Pharmaceuticals Inc (ARNA):企業の財務・戦略的SWOT分析
    Arena Pharmaceuticals Inc (ARNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆